Doctor Christopher Blaum
University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)
Follow
Contributor content
Presentation
Inflammation and cholesterol associated residual cardiovascular risk and its dependence on chronic kidney disease in statin treated patients with coronary artery disease
Presentation
Evaluating risk-based allocation strategies for PCSK9 inhibitors: results from a simulation study in a contemporary ASCVD cohort
Presentation
Presentation
Target populations and treatment cost for bempedoic acid and PCSK9 inhibitors: a simulation study in a contemporary CAD cohort
Presentation
Risk scores for risk stratification in chronic coronary syndrome and their improvement by Gensini and SYNTAX scores
Presentation
The impact of the revised ESC Dyslipidaemia Guidelines on lipid-lowering therapy: simulating the need for PCSK9 inhibition in a contemporary ASCVD cohort
Presentation
